Suður-Afríka - enska - South African Health Products Regulatory Authority (SAHPRA)

sanofi-aventis south africa (pty) ltd - tablet - each tablet contains nicotinic acid 100 mg pentifylline 400 mg

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.2 mg (equivalent: desmopressin, qty 178 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; potato starch - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - oxprenolol hydrochloride - modified-release tablet - 160mg

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg (equivalent: desmopressin, qty 89 microgram) - tablet, uncoated - excipient ingredients: magnesium stearate; lactose monohydrate; potato starch; povidone - minirin tablets are indicated for the treatment of: cranial diabetes insipidus; primary nocturnal enuresis, in patients from 6 years of age with normal ability to concentrate urine, who are refractory to an enuresis alarm, or in whom an enuresis alarm is contraindicated or inappropriate.

Bandaríkin - enska - NLM (National Library of Medicine)

woodward pharma services llc - naproxen (unii: 57y76r9atq) (naproxen - unii:57y76r9atq) - naproxen tablets, ec-naproxen, and naproxen sodium are indicated for: the relief of the signs and symptoms of: - rheumatoid arthritis - osteoarthritis - ankylosing spondylitis - polyarticular juvenile idiopathic arthritis naproxen tablets and naproxen sodium are also indicated for: the relief of signs and symptoms of: - tendonitis - bursitis - acute gout the management of: - pain - primary dysmenorrhea naproxen tablets, ec-naproxen, and naproxen sodium are contraindicated in the following patients: - known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [see warnings and precautions (5.7, 5.9)]. - history of asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, sometimes fatal, anaphylactic reactions to nsaids have been reported in such patients [see warnings and precautions (5.7, 5.8)] . - in the setting of coronary artery bypass graft (cabg) surgery [see warnings and precautions (5.1)] .

Ísrael - enska - Ministry of Health

ferring pharmaceuticals ltd - desmopressin acetate - tablets - desmopressin acetate 0.1 mg - desmopressin - desmopressin - central diabetes insipidus.nocturnal enuresis. treatment of nocturia in adults associated with nocturnal polyuria.

Ísrael - enska - Ministry of Health

ferring pharmaceuticals ltd - desmopressin acetate - tablets - desmopressin acetate 0.2 mg - desmopressin - central diabetes insipidus.nocturnal enuresis. treatment of nocturia in adults associated with nocturnal polyuria.

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sovereign medical ltd - citalopram hydrobromide - oral tablet - 10mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sovereign medical ltd - citalopram hydrobromide - oral tablet - 20mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sovereign medical ltd - citalopram hydrobromide - oral tablet - 40mg